Stay updated on Nab-sirolimus in Severe PAH Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.

Latest updates to the Nab-sirolimus in Severe PAH Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%
- Check19 days agoChange Detected- Updated the revision tag from v3.0.2 to v3.1.0, signaling a new software release.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.6%
- Check48 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location related to Pulmonary Hypertension, while removing extensive drug information and previous location details.SummaryDifference4%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Nab-sirolimus in Severe PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Severe PAH Clinical Trial page.